blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3371227

EP3371227 - CHIMERIC ANTIGEN RECEPTORS TARGETING HER2 [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  30.12.2022
Database last updated on 03.10.2024
FormerThe patent has been granted
Status updated on  21.01.2022
FormerGrant of patent is intended
Status updated on  13.09.2021
FormerExamination is in progress
Status updated on  27.07.2021
FormerGrant of patent is intended
Status updated on  01.03.2021
FormerExamination is in progress
Status updated on  06.05.2019
FormerRequest for examination was made
Status updated on  10.08.2018
FormerThe international publication has been made
Status updated on  13.05.2017
Most recent event   Tooltip13.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 16.10.2024 [2024/42]
Applicant(s)For all designated states
City of Hope
1500 East Duarte Road
Duarte, CA 91010 / US
[2021/33]
Former [2018/37]For all designated states
Priceman, Saul J.
1500 E. Duarte Road
Duarte, California 91010 / US
For all designated states
Forman, Stephen J.
1500 E. Duarte Road
Duarte, CA 91010 / US
For all designated states
Brown, Christine E.
1500 E. Duarte Road
Duarte, CA 91010 / US
Inventor(s)01 / PRICEMAN, Saul J.
1500 E. Duarte Road
Duarte, CA 91010 / US
02 / FORMAN, Stephen J.
1500 E. Duarte Road
Duarte, CA 91010 / US
03 / BROWN, Christine E.
1500 E. Duarte Road
Duarte, CA 91010 / US
 [2022/14]
Former [2021/33]01 / PRICEMAN, Saul J.
1500 E. Duarte Road
Duarte, CA 91010 / US
02 / FOREMAN, Stephen J.
1500 E. Duarte Road
Duarte, CA 91010 / US
03 / BROWN, Christine E.
1500 E. Duarte Road
Duarte, CA 91010 / US
Former [2018/37]01 / see applicant
...
Representative(s)Fish & Richardson P.C.
Highlight Business Towers
Mies-van-der-Rohe-Straße 8
80807 München / DE
[2022/08]
Former [2018/37]Kunz, Herbert
Fish & Richardson P.C.
Highlight Business Towers
Mies-van-der-Rohe-Straße 8
80807 München / DE
Application number, filing date16863128.104.11.2016
[2018/37]
WO2016US60724
Priority number, dateUS201562251052P04.11.2015         Original published format: US 201562251052 P
[2018/37]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2017079694
Date:11.05.2017
Language:EN
[2017/19]
Type: A2 Application without search report 
No.:EP3371227
Date:12.09.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 11.05.2017 takes the place of the publication of the European patent application.
[2018/37]
Type: B1 Patent specification 
No.:EP3371227
Date:23.02.2022
Language:EN
[2022/08]
Type: B8 Corrected title page of specification 
No.:EP3371227
Date:06.04.2022
[2022/14]
Search report(s)International search report - published on:US20.07.2017
(Supplementary) European search report - dispatched on:EP16.07.2018
ClassificationIPC:C07K16/28, C07K16/30, C07K14/705, C12N5/10, C12N15/79, C07K14/725, A61K39/00, A61P35/00, A61K35/17, C07K14/71, C07K16/32, C12N5/0783, C12N15/86
[2021/10]
CPC:
A61P35/00 (EP,CN,IL,KR,RU,US); C12N5/0636 (EP,CN,IL,KR,RU,US); A61K35/12 (RU);
C07K16/32 (EP,CN,IL,KR,US); A61K2239/26 (EP,CN,IL,RU,US); A61K35/17 (KR);
A61K39/4611 (EP,CN,IL,KR,RU,US); A61K39/4631 (EP,CN,IL,KR,RU,US); A61K39/464406 (EP,CN,IL,KR,RU,US);
A61P35/04 (CN,KR); C07K14/70503 (IL,US); C07K14/7051 (EP,CN,IL,KR,US);
C07K14/70514 (CN,KR); C07K14/70517 (CN,KR); C07K14/70521 (EP,CN,IL,KR,US);
C07K14/70578 (CN); C07K14/71 (EP,IL,KR,US); C07K16/2863 (CN,IL,US);
C12N15/85 (RU); C12N15/86 (EP,IL,US); A61K2039/505 (EP,IL,KR,US);
A61K2039/80 (CN); A61K2039/812 (CN); A61K2239/17 (KR);
A61K2239/21 (KR); A61K2239/22 (KR); A61K2239/31 (KR);
A61K2239/47 (KR); C07K2317/524 (IL,US); C07K2317/622 (EP,CN,IL,KR,US);
C07K2317/71 (IL,US); C07K2319/02 (KR); C07K2319/03 (EP,CN,IL,KR,US);
C07K2319/33 (EP,CN,IL,US); C07K2319/74 (CN); C12N2510/00 (CN,KR);
C12N2740/16043 (EP,IL,US); C12N2830/15 (EP,IL,KR,US) (-)
Former IPC [2018/37]C07K16/28, C07K16/30, C07K14/705, C12N5/10, C12N15/79, C07K14/725, A61K39/00, A61P35/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/37]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:CHIMÄRE ANTIGENREZEPTOREN ZUM TARGETING VON HER2[2018/37]
English:CHIMERIC ANTIGEN RECEPTORS TARGETING HER2[2018/37]
French:RÉCEPTEURS ANTIGÉNIQUES CHIMÉRIQUES CIBLANT HER2[2018/37]
Entry into regional phase04.06.2018National basic fee paid 
04.06.2018Search fee paid 
04.06.2018Designation fee(s) paid 
04.06.2018Examination fee paid 
Examination procedure04.06.2018Examination requested  [2018/37]
04.06.2018Date on which the examining division has become responsible
12.02.2019Amendment by applicant (claims and/or description)
09.05.2019Despatch of a communication from the examining division (Time limit: M04)
19.09.2019Reply to a communication from the examining division
26.11.2019Despatch of a communication from the examining division (Time limit: M06)
08.06.2020Reply to a communication from the examining division
16.09.2020Despatch of a communication from the examining division (Time limit: M02)
25.11.2020Reply to a communication from the examining division
02.03.2021Communication of intention to grant the patent
12.07.2021Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
12.07.2021Fee for grant paid
12.07.2021Fee for publishing/printing paid
14.09.2021Communication of intention to grant the patent
13.01.2022Receipt of the translation of the claim(s)
22.02.2022Request for correction of the decision to grant filed
Divisional application(s)EP22157943.6  / EP4074731
Opposition(s)24.11.2022No opposition filed within time limit [2023/05]
Fees paidRenewal fee
04.06.2018Renewal fee patent year 03
27.11.2019Renewal fee patent year 04
27.11.2020Renewal fee patent year 05
29.11.2021Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU04.11.2016
AL23.02.2022
AT23.02.2022
CY23.02.2022
CZ23.02.2022
DK23.02.2022
EE23.02.2022
FI23.02.2022
HR23.02.2022
LT23.02.2022
LV23.02.2022
MC23.02.2022
MK23.02.2022
MT23.02.2022
PL23.02.2022
RO23.02.2022
RS23.02.2022
SE23.02.2022
SI23.02.2022
SK23.02.2022
SM23.02.2022
BG23.05.2022
NO23.05.2022
GR24.05.2022
IS23.06.2022
PT23.06.2022
IE04.11.2022
LU04.11.2022
[2024/42]
Former [2024/27]HU04.11.2016
AL23.02.2022
AT23.02.2022
CY23.02.2022
CZ23.02.2022
DK23.02.2022
EE23.02.2022
FI23.02.2022
HR23.02.2022
LT23.02.2022
LV23.02.2022
MC23.02.2022
MK23.02.2022
PL23.02.2022
RO23.02.2022
RS23.02.2022
SE23.02.2022
SI23.02.2022
SK23.02.2022
SM23.02.2022
BG23.05.2022
NO23.05.2022
GR24.05.2022
IS23.06.2022
PT23.06.2022
IE04.11.2022
LU04.11.2022
Former [2024/21]HU04.11.2016
AL23.02.2022
AT23.02.2022
CY23.02.2022
CZ23.02.2022
DK23.02.2022
EE23.02.2022
FI23.02.2022
HR23.02.2022
LT23.02.2022
LV23.02.2022
MC23.02.2022
PL23.02.2022
RO23.02.2022
RS23.02.2022
SE23.02.2022
SI23.02.2022
SK23.02.2022
SM23.02.2022
BG23.05.2022
NO23.05.2022
GR24.05.2022
IS23.06.2022
PT23.06.2022
IE04.11.2022
LU04.11.2022
Former [2024/18]HU04.11.2016
AL23.02.2022
AT23.02.2022
CZ23.02.2022
DK23.02.2022
EE23.02.2022
FI23.02.2022
HR23.02.2022
LT23.02.2022
LV23.02.2022
MC23.02.2022
PL23.02.2022
RO23.02.2022
RS23.02.2022
SE23.02.2022
SI23.02.2022
SK23.02.2022
SM23.02.2022
BG23.05.2022
NO23.05.2022
GR24.05.2022
IS23.06.2022
PT23.06.2022
IE04.11.2022
LU04.11.2022
Former [2023/48]AL23.02.2022
AT23.02.2022
CZ23.02.2022
DK23.02.2022
EE23.02.2022
FI23.02.2022
HR23.02.2022
LT23.02.2022
LV23.02.2022
MC23.02.2022
PL23.02.2022
RO23.02.2022
RS23.02.2022
SE23.02.2022
SI23.02.2022
SK23.02.2022
SM23.02.2022
BG23.05.2022
NO23.05.2022
GR24.05.2022
IS23.06.2022
PT23.06.2022
IE04.11.2022
LU04.11.2022
Former [2023/37]AL23.02.2022
AT23.02.2022
CZ23.02.2022
DK23.02.2022
EE23.02.2022
FI23.02.2022
HR23.02.2022
LT23.02.2022
LV23.02.2022
MC23.02.2022
PL23.02.2022
RO23.02.2022
RS23.02.2022
SE23.02.2022
SI23.02.2022
SK23.02.2022
SM23.02.2022
BG23.05.2022
NO23.05.2022
GR24.05.2022
IS23.06.2022
PT23.06.2022
LU04.11.2022
Former [2023/30]AL23.02.2022
AT23.02.2022
CZ23.02.2022
DK23.02.2022
EE23.02.2022
FI23.02.2022
HR23.02.2022
LT23.02.2022
LV23.02.2022
MC23.02.2022
PL23.02.2022
RO23.02.2022
RS23.02.2022
SE23.02.2022
SI23.02.2022
SK23.02.2022
SM23.02.2022
BG23.05.2022
NO23.05.2022
GR24.05.2022
IS23.06.2022
PT23.06.2022
Former [2023/10]AL23.02.2022
AT23.02.2022
CZ23.02.2022
DK23.02.2022
EE23.02.2022
FI23.02.2022
HR23.02.2022
LT23.02.2022
LV23.02.2022
PL23.02.2022
RO23.02.2022
RS23.02.2022
SE23.02.2022
SI23.02.2022
SK23.02.2022
SM23.02.2022
BG23.05.2022
NO23.05.2022
GR24.05.2022
IS23.06.2022
PT23.06.2022
Former [2023/01]AL23.02.2022
AT23.02.2022
CZ23.02.2022
DK23.02.2022
EE23.02.2022
FI23.02.2022
HR23.02.2022
LT23.02.2022
LV23.02.2022
PL23.02.2022
RO23.02.2022
RS23.02.2022
SE23.02.2022
SK23.02.2022
SM23.02.2022
BG23.05.2022
NO23.05.2022
GR24.05.2022
IS23.06.2022
PT23.06.2022
Former [2022/49]AT23.02.2022
CZ23.02.2022
DK23.02.2022
EE23.02.2022
FI23.02.2022
HR23.02.2022
LT23.02.2022
LV23.02.2022
PL23.02.2022
RO23.02.2022
RS23.02.2022
SE23.02.2022
SK23.02.2022
SM23.02.2022
BG23.05.2022
NO23.05.2022
GR24.05.2022
IS23.06.2022
PT23.06.2022
Former [2022/48]AT23.02.2022
CZ23.02.2022
DK23.02.2022
EE23.02.2022
FI23.02.2022
HR23.02.2022
LT23.02.2022
LV23.02.2022
PL23.02.2022
RO23.02.2022
RS23.02.2022
SE23.02.2022
SM23.02.2022
BG23.05.2022
NO23.05.2022
GR24.05.2022
IS23.06.2022
PT23.06.2022
Former [2022/47]AT23.02.2022
DK23.02.2022
FI23.02.2022
HR23.02.2022
LT23.02.2022
LV23.02.2022
PL23.02.2022
RO23.02.2022
RS23.02.2022
SE23.02.2022
SM23.02.2022
BG23.05.2022
NO23.05.2022
GR24.05.2022
IS23.06.2022
PT23.06.2022
Former [2022/46]AT23.02.2022
DK23.02.2022
FI23.02.2022
HR23.02.2022
LT23.02.2022
LV23.02.2022
PL23.02.2022
RS23.02.2022
SE23.02.2022
BG23.05.2022
NO23.05.2022
GR24.05.2022
IS23.06.2022
PT23.06.2022
Former [2022/42]AT23.02.2022
FI23.02.2022
HR23.02.2022
LT23.02.2022
LV23.02.2022
PL23.02.2022
RS23.02.2022
SE23.02.2022
BG23.05.2022
NO23.05.2022
GR24.05.2022
IS23.06.2022
PT23.06.2022
Former [2022/39]AT23.02.2022
FI23.02.2022
HR23.02.2022
LT23.02.2022
LV23.02.2022
PL23.02.2022
RS23.02.2022
SE23.02.2022
BG23.05.2022
NO23.05.2022
GR24.05.2022
PT23.06.2022
Former [2022/36]AT23.02.2022
HR23.02.2022
LT23.02.2022
LV23.02.2022
PL23.02.2022
RS23.02.2022
SE23.02.2022
BG23.05.2022
NO23.05.2022
GR24.05.2022
PT23.06.2022
Former [2022/35]HR23.02.2022
LT23.02.2022
RS23.02.2022
SE23.02.2022
BG23.05.2022
NO23.05.2022
PT23.06.2022
Former [2022/34]LT23.02.2022
NO23.05.2022
PT23.06.2022
Former [2022/33]LT23.02.2022
NO23.05.2022
Documents cited:Search[Y]WO2011137245  (ESPERANCE PHARMACEUTICALS INC [US], et al);
 [XY]US2014099309  (POWELL JR DANIEL J [US], et al);
 [XY]US2014140976  (ROSENBLUM MICHAEL G [US], et al);
 [XY]WO2014100385  (ANTHROGENESIS CORP [US]);
International search[Y]US2009252729  (FARRINGTON GRAHAM K [US], et al);
 [A]US2011136173  (PLUECKTHUN ANDREAS [CH], et al);
 [A]US2011294987  (KANAZAKI KENGO [JP], et al);
 [A]US2012301447  (JENSEN MICHAEL C [US]);
 [XY]US2014099309  (POWELL JR DANIEL J [US], et al);
 [A]US2014140976  (ROSENBLUM MICHAEL G [US], et al);
 [X]WO2014100385  (ANTHROGENESIS CORP [US]);
 [A]WO2015028444  (UNIVERSITÄT ZU KÖLN [DE]);
 [A]US2015306141  (JENSEN MICHAEL C [US], et al)
by applicantWO2011137245
 US2014099309
 US2014140976
 WO2014100385
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.